ANDREW CAMPBELL: Open Payments
NPI 1225727423 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 33 payments from 15 companies in 2025. Trend: 2023 $448 · 2024 $753 · 2025 $864
Food & beverage: $864
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $118 |
| Laborie Medical Technologies Corp. | 2 | $115 |
| Astellas Pharma US Inc | 4 | $95 |
| Endo USA, Inc. | 4 | $81 |
| Boston Scientific Corporation | 2 | $70 |
| Janssen Biotech, Inc. | 3 | $69 |
| UROGEN PHARMA, INC. | 2 | $56 |
| Ferring Pharmaceuticals Inc. | 2 | $54 |
| ABBVIE INC. | 3 | $53 |
| COLOPLAST CORP | 2 | $38 |
Products named: GEMTESA, Xtandi, ERLEADA, AVEED, JELMYTO, ADSTILADRIN, LUPRON DEPOT, AMS 700.
Industry payments across SC — which companies pay providers there.
